Skip to main content

Table 1 Baseline characteristics of the participants

From: Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID-19)

Patient’s serial number Date of symptom onset Date of hospital admission Date of ICU admission Underlying disorders Medications received before the onset of hemoperfusion Vital signs before the first session of hemoperfusion Date of hemoperfusion sessions
Body Temperature (°C) Blood Pressure (mm/Hg) Pulse Rate (per minute) Respiratory Rate (per minute) The 1st The 2nd The 3rd
1 2020-03-05 2020-03-10 2020-3-13 Single kidney and chronic kidney disease Linezolid, Kaletra (Lopinavir 400 and Ritonavir 100), Hydroxychloroquine, Meropenem, Oseltamivir 75 36.2 131/70 67 24 2020-03-17 2020-03-19 2020-03-21
2 2020-03-05 2020-03-11 2020-03-14 Pneumoconiosis Vancomycin, Linezolid, Kaletra (Lopinavir 400 and Ritonavir 100), Hydroxychloroquine, Oseltamivir 75 37.0 153/100 99 28 2020-03-17 2020-03-18 2020-03-20
3 2020-03-08 2020-03-11 2020-03-13 No Vancomycin, Kaletra (Lopinavir 400 and Ritonavir 100), Hydroxychloroquine, Meropenem, Oseltamivir 75 38.0 100/60 100 25 2020-03-18 2020-03-19 2020-03-20
4 2020-03-10 2020-03-14 2020-03-15 No Vancomycin, Linezolid, Kaletra (Lopinavir 400 and Ritonavir 100), Hydroxychloroquine, Meropenem, Oseltamivir 75 37.5 112/80 80 23 2020-03-16 2020-03-17 2020-03-18
5 2020-03-10 2020-03-14 2020-03-15 No Vancomycin, Kaletra (Lopinavir 400 and Ritonavir 100), Azithromycin, Hydroxychloroquine, Meropenem, Oseltamivir 75 37.0 130/75 85 40 2020-03-15 2020-03-16 2020-03-18
6 2020-03-10 2020-03-15 2020-03-17 No Vancomycin, Kaletra (Lopinavir 400 and Ritonavir 100), Hydroxychloroquine, Meropenem 37.7 143/88 93 22 2020-03-23 2020-03-24 2020-03-25
7 2020-03-10 2020-03-16 2020-03-19 Malignancy (Leukemia) Vancomycin, Kaletra (Lopinavir 400 and Ritonavir 100), Hydroxychloroquine, Meropenem, Oseltamivir 75 36.8 123/96 108 30 2020-03-21 2020-03-22 2020-03-23
8 2020-03-10 2020-03-16 2020-03-19 Cardiovascular disorders, Hypertension, Coronary artery bypass graft surgery, Diabetes mellitus, Parkinson, Rheumatoid arthritis Vancomycin, Kaletra (Lopinavir 400 and Ritonavir 100), Hydroxychloroquine, Meropenem, Oseltamivir 75 36.5 110/70 100 18 2020-03-20 2020-03-21 2020-03-22
9 2020-03-10 2020-03-17 – Diabetes mellitus Linezolid, Kaletra (Lopinavir 400 and Ritonavir 100), Meropenem 37.7 110/70 91 35 2020-03-21 2020-03-22 2020-03-23
10 2020-03-20 2020-03-23 2020-03-27 Cardiovascular disorders, Hypertension, Diabetes mellitus, Chronic kidney disease Linezolid, Kaletra (Lopinavir 400 and Ritonavir 100), Hydroxychloroquine, Meropenem 38.5 100/57 57 26 2020-03-26 2020-03-30 2020-04-01
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us